Mental Health Clinics in Henderson, NE Accepting Medicare
2 Mental Health Clinics found. Showing 1 - 2
 Sandra Hale Kroeker, Pc Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 1080 17th St, Henderson, NE 68371 Phone: 402-723-4883 Fax: 402-723-4914 |
Grace Childrens Home Inc Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1033 N Main, Henderson, NE 68371 Phone: 402-723-5725 Fax: 402-723-5718 |
News Archive
New microscopy technique can improve understanding of human tissues, biomaterials
Research from North Carolina State University demonstrates that a relatively new microscopy technique can be used to improve our understanding of human tissues and other biomedical materials. The study focused specifically on eye tissues, which are damaged by scarring in diabetic patients.
ARC selects Elsevier's Scopus as bibliometric provider for 2015 ERA assessment
Third time consecutive selection underscores Scopus' continuing relevance and value in supporting research excellence in Australia
Researchers find link between low general cognitive ability and elevated risk of not taking statins
After a heart attack, it is important for patients to take medication that lowers cholesterol levels. In a new study published in the European Journal of Preventive Cardiology, researchers at Uppsala and Umeå Universities have found that general cognitive ability (intelligence) has a bearing, in the first year and two years after the heart attack, on how well men take statins prescribed for them.
Blood-based gene expression test more effective in ruling out obstructive CAD
A blood-based gene expression test was found to be more effective for ruling out obstructive coronary artery disease in stable symptomatic patients than myocardial perfusion imaging (MPI), a common test that uses a radioactive agent to evaluate the blood flow and function of the heart.
Phase 1b clinical trial results of PEG-Interferon lambda to be presented
Bristol-Myers Squibb Company and ZymoGenetics, Inc. (NASDAQ:ZGEN) announced that final results from a Phase 1b clinical trial in patients with hepatitis C (HCV) treated with PEG-Interferon lambda, a new class of interferon, in combination with ribavirin will be presented at the American Association for the Study of Liver Diseases (AASLD) annual meeting October 30–November 3, 2009, in Boston.
› Verified 5 days ago